150 related articles for article (PubMed ID: 12425514)
1. Ifosfamide-induced encephalopathy.
Gonzalez-Angulo AM; Orzano JA; Davila E
South Med J; 2002 Oct; 95(10):1215-7. PubMed ID: 12425514
[TBL] [Abstract][Full Text] [Related]
2. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
[TBL] [Abstract][Full Text] [Related]
3. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
[TBL] [Abstract][Full Text] [Related]
4. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
5. Role of thiamine in managing ifosfamide-induced encephalopathy.
Hamadani M; Awan F
J Oncol Pharm Pract; 2006 Dec; 12(4):237-9. PubMed ID: 17156595
[TBL] [Abstract][Full Text] [Related]
6. Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer.
Pronzato P; Vigani A; Pensa F; Vanoli M; Tani F; Vaira F
Am J Clin Oncol; 1997 Oct; 20(5):519-21. PubMed ID: 9345341
[TBL] [Abstract][Full Text] [Related]
7. Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis.
Lima MV; Ferreira FV; Macedo FY; de Castro Brito GA; Ribeiro RA
Cancer Chemother Pharmacol; 2007 Apr; 59(5):643-50. PubMed ID: 16947012
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Semin Oncol; 1996 Jun; 23(3 Suppl 6):97-8. PubMed ID: 8677458
[TBL] [Abstract][Full Text] [Related]
9. Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
Goren MP; Epelman S; Bush DA
Cancer Chemother Pharmacol; 2004 Sep; 54(3):237-40. PubMed ID: 15184993
[TBL] [Abstract][Full Text] [Related]
10. [Cyclophosphamide-induced bladder cancer: three case reports].
Kijima T; Masuda H; Suzuki M; Okada Y; Yano M; Hyochi N; Fujii Y; Kawakami S; Hayashi T; Kobayashi T; Kihara K
Hinyokika Kiyo; 2003 Aug; 49(8):483-6. PubMed ID: 14518387
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of mesna with ifosfamide.
Goren MP
Semin Oncol; 1996 Jun; 23(3 Suppl 6):91-6. PubMed ID: 8677457
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide neurotoxicity: an atypical presentation with psychiatric manifestations.
Kerdudo C; Orbach D; Sarradet JL; Doz F
Pediatr Blood Cancer; 2006 Jul; 47(1):100-2. PubMed ID: 16261598
[TBL] [Abstract][Full Text] [Related]
13. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH
Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353
[TBL] [Abstract][Full Text] [Related]
14. Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide.
Mace JR; Keohan ML; Bernardy H; Junge K; Niebch G; Romeis P; Thoma A; Wagner T; Mueller U; Demetri G; Baker LH
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5829-34. PubMed ID: 14676103
[TBL] [Abstract][Full Text] [Related]
15. [Glucose infusions--a possible effective therapeutic option in ifosfamide-induced encephalopathy].
Kellner O; Dempke W; Schmoll HJ
Dtsch Med Wochenschr; 1999 Sep; 124(37):1086-7. PubMed ID: 10520310
[No Abstract] [Full Text] [Related]
16. Successful treatment of ifosfamide neurotoxicity with dexmedetomidine.
Bernard PA; McCabe T; Bayliff S; Hayes D
J Oncol Pharm Pract; 2010 Dec; 16(4):262-5. PubMed ID: 20118215
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment with methylene blue of ifosfamide-induced central nervous system effects].
Demandt M; Wandt H
Dtsch Med Wochenschr; 1996 Apr; 121(17):575. PubMed ID: 8620831
[No Abstract] [Full Text] [Related]
18. Nonconvulsive status epilepticus due to ifosfamide.
Kilickap S; Cakar M; Onal IK; Tufan A; Akoglu H; Aksoy S; Erman M; Tekuzman G
Ann Pharmacother; 2006 Feb; 40(2):332-5. PubMed ID: 16449538
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ifosfamide encephalopathy with intravenous thiamin.
Buesa JM; García-Teijido P; Losa R; Fra J
Clin Cancer Res; 2003 Oct; 9(12):4636-7. PubMed ID: 14555540
[No Abstract] [Full Text] [Related]
20. Results of a phase II clinical trial on the use of ifosfamide for treatment of cats with vaccine-associated sarcomas.
Rassnick KM; Rodriguez CO; Khanna C; Rosenberg MP; Kristal O; Chaffin K; Page RL
Am J Vet Res; 2006 Mar; 67(3):517-23. PubMed ID: 16506920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
